Scott Braunstein serves as an Operating Partner at Aisling Capital. He is Senior Vice President, Strategy and Corporate Development at Pacira Pharmaceuticals. Scott Braunstein spent 12 years as a Healthcare Analyst and Portfolio Manager at J.P. Morgan Asset Management, where he invested in and conducted diligence on a wide variety of pharmaceutical products and product candidates. He reviewed pharmaceutical company strategies, business models and management teams, and provided stock recommendations for the J.P. Morgan Asset Equity Group.Scott Braunstein serves as a director of Esperion Therapeutics, STAT Medical and the Cornell Alumni Association for the College of Agriculture and Life Sciences.Scott Braunstein received his M.D. from the Albert Einstein College of Medicine and completed his residency in internal medicine at Cornell University-New York Hospital. He received his B.S. from Cornell University.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Marinus Pharmaceuticals | Chief Executive Officer | Aug 1, 2019 | — | Detail |
Marinus Pharmaceuticals | Board Member | Jan 1, 2018 | — | Detail |
Alaunos Therapeutics | Board Member | Jan 1, 2018 | — | Detail |